惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

V
Visual Studio Blog
罗磊的独立博客
小众软件
小众软件
T
Tailwind CSS Blog
宝玉的分享
宝玉的分享
博客园_首页
N
Netflix TechBlog - Medium
B
Blog
Recent Announcements
Recent Announcements
Y
Y Combinator Blog
Blog — PlanetScale
Blog — PlanetScale
L
LangChain Blog
F
Fortinet All Blogs
The GitHub Blog
The GitHub Blog
Stack Overflow Blog
Stack Overflow Blog
C
Check Point Blog
Last Week in AI
Last Week in AI
Jina AI
Jina AI
V
V2EX
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
博客园 - 叶小钗
博客园 - 【当耐特】

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Veracyte, Inc. (VCYT) Q1 2026 Earnings Call Transcript
SA Transcripts · 2026-05-06 · via All Articles on Seeking Alpha

Q1: 2026-05-05 Earnings Summary

EPS of $0.52 beats by $0.19

 | 

Revenue of

$139.07M

(21.49% Y/Y)

beats by $8.71M

Veracyte, Inc. (VCYT) Q1 2026 Earnings Call May 5, 2026 4:30 PM EDT

Company Participants

Kelly Gura - Director of Investor Relations
Marc Stapley - CEO & Director
Rebecca Chambers - Executive VP & CFO
John Leite - Global Chief Commercial Officer

Conference Call Participants

Puneet Souda - Leerink Partners LLC, Research Division
Douglas Schenkel - Wolfe Research, LLC
Subhalaxmi Nambi - Guggenheim Securities, LLC, Research Division
Mason Carrico - Stephens Inc., Research Division
Kyle Mikson - Canaccord Genuity Corp., Research Division

Presentation

Operator

Good day and thank you for standing by. Welcome to Veracyte First Quarter 2026 Financial Results Webcast Call. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Kelly Gura, Director of Investor Relations.

Kelly Gura
Director of Investor Relations

Good afternoon, everyone, and thank you for joining us today to review Veracyte's First quarter 2026 financial results.

Joining me on the call are Marc Stapley, our Chief Executive Officer; and Rebecca Chambers, our Chief Financial Officer. Dr. John Leite, our Chief Commercial Officer, will also be available for Q&A. Earlier this afternoon, we issued a press release detailing our first quarter financial results, and we posted an accompanying presentation in the Investors section of our website.

Before we begin, I'd like to remind you that statements we make during this call will include forward-looking statements as defined under applicable securities laws. Forward-looking statements are subject to risks and uncertainties, and the company can give no assurance they will prove to be correct. Additionally, we are not under any obligation to provide further updates on our business trends or our performance during the quarter.

To better understand the risks and uncertainties that could cause actual results to differ, we refer you to the documents that Veracyte files